Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Home
Investire
Azioni
U.S.A.
NASDAQ
ChipMOS Technologies Inc (IMOS)
ChipMOS Technologies Inc (IMOS) Opzioni

ChipMOS Technologies Inc (IMOS)

73,02

9,09

( 14,22% )

Aggiornato: 19:52:21

ChipMOS Technologies Inc ([symbol]) Opzioni

IMOS Flusso Di Opzioni

Call

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
30,00	40,90	45,50	0,00	43,20	0,00	0,00 %	0	0	-
35,00	36,00	40,50	0,00	38,25	0,00	0,00 %	0	0	-
40,00	30,60	35,50	0,00	33,05	0,00	0,00 %	0	0	-
45,00	25,90	30,50	0,00	28,20	0,00	0,00 %	0	0	-
50,00	21,00	25,50	9,70	23,25	0,00	0,00 %	0	2	-
55,00	16,00	20,90	6,30	18,45	0,00	0,00 %	0	0	-
60,00	11,50	16,30	4,00	13,90	0,00	0,00 %	0	5	-
65,00	7,00	11,50	3,85	9,25	0,00	0,00 %	0	2	-
70,00	3,50	8,00	6,90	5,75	4,10	146,43 %	16	18	18:31:52
75,00	1,00	5,50	2,80	3,25	2,75	5.500,00 %	12	7	17:05:05
80,00	0,70	1,85	1,50	1,275	-1,05	-41,18 %	51	5	19:00:55
85,00	0,00	5,00	0,00	0,00	0,00	0,00 %	0	0	-
90,00	0,00	5,00	0,00	0,00	0,00	0,00 %	0	0	-
95,00	0,00	5,00	0,00	0,00	0,00	0,00 %	0	0	-

Discussioni in tempo reale e idee di trading: Fai trading con fiducia con la nostra potente piattaforma.

Premium

Put

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
30,00	0,00	5,00	0,00	0,00	0,00	0,00 %	0	0	-
35,00	0,00	5,00	0,00	0,00	0,00	0,00 %	0	0	-
40,00	0,00	5,00	0,00	0,00	0,00	0,00 %	0	0	-
45,00	0,00	1,80	0,55	0,55	0,00	0,00 %	0	1	-
50,00	0,00	5,00	1,02	1,02	0,00	0,00 %	0	3	-
55,00	0,15	5,00	2,55	2,575	0,00	0,00 %	0	2	-
60,00	0,75	5,00	3,45	2,875	0,00	0,00 %	0	6	-
65,00	0,50	5,00	0,00	2,75	0,00	0,00 %	0	0	-
70,00	2,00	5,00	7,60	3,50	0,00	0,00 %	0	11	-
75,00	2,50	7,40	0,00	4,95	0,00	0,00 %	0	0	-
80,00	6,20	10,80	0,00	8,50	0,00	0,00 %	0	0	-
85,00	10,20	15,00	0,00	12,60	0,00	0,00 %	0	0	-
90,00	15,00	19,50	0,00	17,25	0,00	0,00 %	0	0	-
95,00	19,90	24,50	0,00	22,20	0,00	0,00 %	0	0	-

Più Attivi
% Guadagnanti
% Perdenti

Simbolo	Prezzo	Vol.
LHSWLianhe Sowell International Group Ltd	US$ 5,31 (195,00%)	90,28M
ZCMDZhongchao Inc	US$ 2,225 (100,45%)	33,81M
KIDZKIDZ AI Inc	US$ 1,2199 (79,42%)	167,86M
INLFINLIF Limited	US$ 7,68 (77,78%)	1,65M
LUCYInnovative Eyewear Inc	US$ 1,3187 (73,51%)	170,91M
REEREE Automotive Ltd	US$ 0,0762 (-63,68%)	7,39M
ALARAlarum Technologies Ltd	US$ 3,04 (-52,13%)	3,46M
JEM707 Cayman Holdings Ltd	US$ 1,53 (-33,48%)	3,52M
JLHLJulong Holding Limited	US$ 5,08 (-30,70%)	2,27M
BIYABaiya International Group Inc	US$ 0,4679 (-25,43%)	4,17M
YHCLQR House Inc	US$ 0,03585 (-20,51%)	411,05M
LUCYInnovative Eyewear Inc	US$ 1,3187 (73,51%)	170,91M
KIDZKIDZ AI Inc	US$ 1,2199 (79,42%)	167,86M
LHSWLianhe Sowell International Group Ltd	US$ 5,31 (195,00%)	90,28M
AALAmerican Airlines Group Inc	US$ 17,9401 (0,11%)	87,56M

BBANBOB

BBANBOB 3 minuti fa

GENERALLY TAKE 2 TO 3 DAYS FOR NEWS TO DIGEST BEFORE FOLKS REACT.

The Truth Hurts

The Truth Hurts 3 minuti fa

Assuming that would occur of course.

AngeloFoca

AngeloFoca 4 minuti fa

Do you think the PSM data was developed to support an appeal of a CHM Letter issued after the November 2025 CHM meeting?
Again with this "CHM Letter" THAT WAS NEVER ISSUED!!!

.

stevhoff

stevhoff 4 minuti fa

That's right and that's a lot of dilution when the conversion occurs. On a di;luted per share basis, there's nothing there.

MarauderWarlock33

MarauderWarlock33 5 minuti fa

https://www.gov.uk/government/news/nhs-patients-get-faster-access-to-medicines-under-new-pilots

NICE updates.

waterpro42

waterpro42 5 minuti fa

Ok me and a Canadian buddy just slapped us to 1 MM, somebody else take the baton.

DrHigh

DrHigh 5 minuti fa

3 million shares traded after great news and we are red. lets see what our OS does later this week. There has been a consistent delay to OS being updated. I bet more than half of today's shares comes from dilution

Jack_Herer

Jack_Herer 5 minuti fa

We will release the results when we’re permitted to do so.

Around 4 beers past beer o’clock here in Accra. But I’m celebrating, so give me a break!

brooktrail1933

brooktrail1933 5 minuti fa

I'm not sure I agree with your analysis.
The first reason is the flurry of activity on the part of NWBO right after the November CHM meeting, at which we know the MAA was discussed. That's not the sort of thing a company would do if it knew it would be another year before their treatment wou

betman

betman 5 minuti fa

400,000 at .0001 . Did we just come off the expert market ?

reachjo

reachjo 6 minuti fa

underpar71

underpar71 7 minuti fa

And, in the midst of all the bickering of blindfolded shareholders, the stock will go red again today.

The Truth Hurts

The Truth Hurts 7 minuti fa

Yes, those are from each acquisition and are "insider" control shares. No?

JJ24

JJ24 8 minuti fa

Would be nice to see some volume before update . It’s gotta be something super juicy to get a group to buy .

z-money

z-money 8 minuti fa

I being impatient, I know. But I wish they would get their act together already. LOL.

SDCRBS

SDCRBS 8 minuti fa

⭐ Executive Summary: Melvin Ejiogu (CEO, VeeMost Technologies)
🎓 Education & Credentials
Melvin holds a Bachelor’s degree in Business Administration (Corporate Finance) from the University of Akron in Ohio .

He also holds top-level IT certifications, including th

stevhoff

stevhoff 9 minuti fa

Series E preferred:3,898,500. Each share convertibl;e into 1000 shares of common.

US Market News

US Market News 9 minuti fa

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
Business Wire TEPKINLY® (epcori

US Market News

US Market News 9 minuti fa

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
PR Newswire (US) TEPKINLY

US Market News

US Market News 9 minuti fa

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
PR Newswire (US) TEPKINLY

nathanial

nathanial 9 minuti fa

Number 1 on the breakout boards.

US Market News

US Market News 9 minuti fa

Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTSJuly 6, 2026 1:50 PM
PR Newswire (US) class="legendSpanClass"LOS ANGELES, class="legendSpanClass"July 6, 2026 /PRNewswire/ --

rmoss

rmoss 9 minuti fa

Hell he could be just trying to keep his atm open lol

Aquahoya

Aquahoya 10 minuti fa

One more MM. Cant be much

Myth

Myth 10 minuti fa

"Blacktop Horizon" Justin Johnson live

https://www.youtube.com/watch?v=uElBgnt45RA

ChipMOS Technologies

AMC Entertainment

BlackBerry Ltd.

Placer Creek Mining (EM)

Raymond James Financial

Excellon Resources (PK)

Golden Entertainment

Lionsgate Studios

Reitmans Canada

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN

Hai già un account? Accedi

Non hai un account? Registrati

Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.